🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06543862
Recruiting Not applicable

Autonomous Artificial Intelligence Versus AI Assisted Human Optical Diagnosis

NCT06543862 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-11-15
Last updated
2026-09-21

Condition(s) studied

Colonic PolypArtificial Intelligence

Investigational drug(s) / intervention(s)

CADx (AI) system

CADx (AI) system: The CADx system will be used to predict the histopathology of the polyp detected.

Study summary

Computer-aided image-enhanced endoscopy can predict the nature of colorectal polyps with over 90% accuracy. This technology uses artificial intelligence (AI) to analyze video recordings of polyps, learning to make diagnoses in real-time. This means that doctors can get immediate predictions about small polyps during the procedure, reducing the need for separate pathology exams and saving costs, ultimately improving patient care.

Human and AI interactions are complex and a framework to reap synergistic effects CADx systems when used by humans to harness optimal performance needs to be established. AI solutions in medicine are usually developed to be used as assistive devices, however, then they rely on humans to correct AI errors. Optical polyp diagnosis is a complex task. Non experts usually achieve diagnostic accuracy in 70-80%. CADx systems have a similar diagnostic accuracy when used autonomously. Clinical evaluation of CADx systems showed that CADx assisted OD performs equally to the operator performance when using non CADx assisted OD. To harness a benefit of clinical CADx implementation we would have to find a way that synergies between human and CADx come into play to eliminate cases in which CADx assisted and/ or human OD results in low diagnostic accuracy and also addresses the problem of serrated polyp recognition.

Eligibility

Sex
ALL
Min age
45 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Indication for full colonoscopy. Exclusion Criteria: * Known inflammatory bowel disease * Active colitis * coagulopathy * familial polyposis syndrome * poor general health, defined as an American Society of Anesthesiologists class \>3 * emergency colonoscopy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ghislaine Ahoua Montreal Quebec Recruiting

More Centre hospitalier de l'Université de Montréal (CHUM) trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06543862 on ClinicalTrials.gov ↗ ← All trials in Canada